Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling
Author(s) -
Dongshan Zhu,
Jingyao Dong,
Yaoyao Xu,
Xintong Zhang,
Shibo Fu,
Wei Liu
Publication year - 2020
Publication title -
medical science monitor
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.636
H-Index - 85
eISSN - 1643-3750
pISSN - 1234-1010
DOI - 10.12659/msm.927106
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , cell growth , cancer research , cell cycle , mapk/erk pathway , viability assay , biology , apoptosis , rptor , signal transduction , microbiology and biotechnology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom